Grimaldi Roberta, Swann Jonathan R, Vulevic Jelena, Gibson Glenn R, Costabile Adele
1Department of Food and Nutritional Sciences,University of Reading,Reading RG6 6AP,UK.
2Division of Computational and Systems Medicine,Imperial College,London SW7 2AZ,UK.
Br J Nutr. 2016 Aug;116(3):480-6. doi: 10.1017/S0007114516002269. Epub 2016 Jun 8.
Prebiotic oligosaccharides have the ability to generate important changes in the gut microbiota composition that may confer health benefits to the host. Reducing the impurities in prebiotic mixtures could expand their applications in food industries and improve their selectivity and prebiotic effect on the potential beneficial bacteria such as bifidobacteria and lactobacilli. This study aimed to determine the in vitro potential fermentation properties of a 65 % galacto-oligosaccharide (GOS) content Bimuno® GOS (B-GOS) on gut microbiota composition and their metabolites. Fermentation of 65 % B-GOS was compared with 52 % B-GOS in pH- and volume-controlled dose-response anaerobic batch culture experiments. In total, three different doses (1, 0·5 and 0·33 g equivalent to 0·1, 0·05 and 0·033 g/l) were tested. Changes in the gut microbiota during a time course were identified by fluorescence in situ hybridisation, whereas small molecular weight metabolomics profiles and SCFA were determined by 1H-NMR analysis and GC, respectively. The 65 % B-GOS showed positive modulation of the microbiota composition during the first 8 h of fermentation with all doses. Administration of the specific doses of B-GOS induced a significant increase in acetate as the major SCFA synthesised compared with propionate and butyrate concentrations, but there were no significant differences between substrates. The 65 % B-GOS in syrup format seems to have, in all the analysis, an efficient prebiotic effect. However, the applicability of such changes remains to be shown in an in vivo trial.
益生元低聚糖能够引起肠道微生物群组成的重要变化,这可能会给宿主带来健康益处。减少益生元混合物中的杂质可以扩大其在食品工业中的应用,并提高其对双歧杆菌和乳酸杆菌等潜在有益细菌的选择性和益生元效应。本研究旨在确定65%低聚半乳糖(GOS)含量的比穆诺®低聚半乳糖(B-GOS)对肠道微生物群组成及其代谢产物的体外潜在发酵特性。在pH值和体积控制的剂量反应厌氧分批培养实验中,将65% B-GOS的发酵与52% B-GOS进行了比较。总共测试了三种不同剂量(1、0.5和0.33 g,相当于0.1、0.05和0.033 g/l)。通过荧光原位杂交确定了随时间变化的肠道微生物群的变化,而小分子代谢组学图谱和短链脂肪酸分别通过1H-NMR分析和气相色谱法测定。在所有剂量下,65% B-GOS在发酵的前8小时内对微生物群组成显示出正向调节作用。与丙酸和丁酸浓度相比,特定剂量的B-GOS给药导致作为主要合成短链脂肪酸的乙酸盐显著增加,但底物之间没有显著差异。糖浆形式的65% B-GOS在所有分析中似乎都具有有效的益生元作用。然而,这种变化的适用性仍有待在体内试验中得到证实。